Front Cover; Contents; Preface; Acknowledgments; Author; Introduction: The Good, the Bad, the Ugly, and the Necessary; Chapter 1: H.R. 3204: The Journey and Expected Destination; Chapter 2: The World of Human DrugCompounding: Hope and Change; Chapter 3: Pharmacy Compounding: The Supply Chain World; Chapter 4: Track and Trace: Not Hide and Seek; Chapter 5: Land of the Giants-and Land of the Totes; Chapter 6: The Customer/Patient Touchpoint-Literally and Electronically: Internet Pharmacies, Pill Mills, and Other Lurking Dangers; Chapter 7: When Things Go Bump in the Night: Reverse Logistics
Chapter 8: All Those "Lettered" Government AgenciesChapter 9: Pulling It All Together: Public Policy and Other Items of Note; Chapter 10: Drug Quality and Security Hall of Fame; Back Cover
Summary
Error-proofing in the production process of pharmaceuticals isn't just a matter of good business, it has life-and-death implications for consumers. To that end, the 2013 Drug Quality and Security Act in large part requires new mandates on tracking and tracing chain of custody in the supply chain. Pharmaceutical Supply Chain: Drug Quality and Security Act overviews the new mandate and its implications, including implementation strategies for track-and-trace programs along with presenting a fuller understanding of the mechanics of intergovernmental policies and oversights. The book focuses on the
